// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Predictors of patterns of response following specific inhalation challenge testing with low molecular weight agents.

Vicky Moore - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effect of breathing retraining on patients with difficult asthma and dysfunctional breathing

Lone Schaadt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD

Ulf Nilsson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Understanding referral to Pulmonary Rehabilitation for COPD patients by Primary Health Care staff - a qualitative study using the Theoretical Domains Framework.

Jane Watson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Compliance with recommendation for respiratory sampling in diagnosis of Tuberculosis(NICE guideline NG33)

Hnin Wint Wint Aung - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Increased right ventricular systolic:diastolic duration ratiopredicts mortality in idiopathic pulmonary arterial hypertension

Irena Ivanac Vranesic - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Mortality rates of COPD Patients in UK Electronic Health Records (Clinical Practice Research Datalink)

Alicia Gayle - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

‘E-Noting Nodulomics’: Automating Electronic Clinical Data Mining and Analysis of Pulmonary Nodules Using a Python Algorithm

Richard Lee - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perceptions among primary care staff towards financial incentives to promote implementation of asthma self-management: a qualitative study in Northern Ireland

Tracy Jackson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry

Anthony De Soyza - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Inflammatory bowel disease

N/A

Non-invasive measurement of lung inhomogeneity in patients who suffered a primary spontaneous pneumothorax

Rob Hallifax - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary spontaneous pneumothorax

N/A

Hyperpolarised 129Xenon MRI can identify ventilation abnormalities in patients suffering with primary spontaneous pneumothorax

Rob Hallifax - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary spontaneous pneumothorax

N/A

Antifibrotic choice in idiopathic pulmonary fibrosis

Conal Hayton - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial

Maggie Tabberer - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Prevalence and Impact of Lung Resection in Primary Ciliary Dyskinesia: a cohort and nested case-control study

Panayiotis Kouis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Extrafine beclometasone dipropionate, formoterol fumarate, glycopyrronium (BDP/FF/G) and exacerbation recurrence: post-hoc analysis of the TRIBUTE study.

Leonardo Fabbri - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

beclometasone dipropionate

A review of cleaning agent-related occupational asthma from Birmingham, UK (2000-16)

Gareth Walters - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Engaging people at highest risk of an asthma attack

Catherine Broadbent - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis

Norrice Liu - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Lung Function Decline In Occupational Asthma (OA): A Comparison of Irritant-Induced Asthma and Sensitising OA.

Maximillian Thomas - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Prulifloxacin

Copyright © 2026. QuantiNova All rights reserved